glp 1 agonists microdose Is GLP-1 microdosing for weight loss safe and effective? Microdosing GLP-1 for Weight Loss
Description
M., Gratzl S., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity, JAMA Internal Medicine 184 (2024): 10561064
35 Significant advances in pharmacological treatment have primarily focused on HFrEF, the current therapy for which is built on four key pillars: angiotensin receptorneprilysin inhibitor (ARNI) or, alternatively, ACE inhibitors or angiotensin receptor blockers
The GH/IGF1 Axis and Signaling Pathways in the Muscle and Bone: Mechanisms Underlying Age-Related Skeletal Muscle Wasting and Osteoporosis
[Google Scholar] 90
As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual- or tri-receptor agonists (incretin mimetics) redefine metabolic health management, oncology clinicians increasingly face questions about their use during and after active cancer treatment
Molecular Metabolism , 11, 1-14
